These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36703271)

  • 21. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
    Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD
    Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions.
    Langevitz P; Buskila D; Lee P; Urowitz MB
    J Rheumatol; 1989 Nov; 16(11):1433-5. PubMed ID: 2600942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Raynaud's phenomenon and digital ischemia.
    Herrick AL
    Curr Rheumatol Rep; 2013 Jan; 15(1):303. PubMed ID: 23292819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate.
    Hughes M; Moore T; Manning J; Wilkinson J; Dinsdale G; Roberts C; Murray A; Herrick AL
    Microvasc Res; 2017 May; 111():32-36. PubMed ID: 28027937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
    Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
    Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.
    Blaise S; Roustit M; Forli A; Imbert B; Cracowski JL
    Int Wound J; 2017 Dec; 14(6):978-981. PubMed ID: 28303689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.
    De Lorenzis E; Natalello G; Verardi L; Cerasuolo PG; Gigante L; D'Agostino MA; Bosello SL
    Microvasc Res; 2022 Nov; 144():104404. PubMed ID: 35835174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
    Botzoris V; Drosos AA
    Joint Bone Spine; 2011 Jul; 78(4):341-6. PubMed ID: 21183379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hand involvement in systemic sclerosis].
    Mouthon L
    Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capillary Desertification and Refractory Digital Ulcers in Systemic Sclerosis.
    Zanatta E; Schiavon F; Cozzi F
    J Clin Rheumatol; 2019 Sep; 25(6):e86. PubMed ID: 29561473
    [No Abstract]   [Full Text] [Related]  

  • 31. Ischemic finger ulcer as a presenting symptom of systemic sclerosis.
    Balbir-Gurman A; Markovits D; Nahir AM; Rozin A; Braun-Moscovici Y
    Isr Med Assoc J; 2005 Aug; 7(8):531-2. PubMed ID: 16106783
    [No Abstract]   [Full Text] [Related]  

  • 32. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic sclerosis in adults. Part II: management and therapeutics.
    Jerjen R; Nikpour M; Krieg T; Denton CP; Saracino AM
    J Am Acad Dermatol; 2022 Nov; 87(5):957-978. PubMed ID: 35131401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of digital ulcers in patients with systemic sclerosis].
    Riemekasten G; Hoffmann U; Sunderkötter C; Weiss N; Kuhn A;
    Dtsch Med Wochenschr; 2012 Jan; 137(1-2):34-40. PubMed ID: 22180282
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience.
    Nagarajan M; McArthur P
    Rheumatol Int; 2021 May; 41(5):943-949. PubMed ID: 32447423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischaemic ulcers on the toes secondary to Raynaud phenomenon in a patient with systemic sclerosis successfully treated with botulinum toxin.
    Garrido-Ríos AA; González-Olivares M; Navarro-Vidal B; Martínez-Morán C; Borbujo J
    Clin Exp Dermatol; 2018 Jun; 43(4):503-505. PubMed ID: 29274125
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary Clinical and Laser Speckle Contrast Analysis Data on Selexipag Efficacy for the Treatment of Digital Vasculopathy in Systemic Sclerosis.
    Di Battista M; Della Rossa A; Da Rio M; De Mattia G; Morganti R; Mosca M
    J Rheumatol; 2023 Aug; 50(8):1029-1031. PubMed ID: 37003608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible benefit of tadalafil cream for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
    Fernández-Codina A; Kazem M; Pope JE
    Clin Rheumatol; 2020 Mar; 39(3):963-965. PubMed ID: 32016657
    [No Abstract]   [Full Text] [Related]  

  • 39. [Raynaud syndrome].
    Knorr M; Schmid A; steurer J; Vetter W
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):893-6. PubMed ID: 3738337
    [No Abstract]   [Full Text] [Related]  

  • 40. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil.
    Shah AA; Schiopu E; Chatterjee S; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V
    J Rheumatol; 2016 Sep; 43(9):1665-71. PubMed ID: 27307535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.